Publications by authors named "Jane Jaquith"

Claim this Profile
R
Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study.
Matthew J Samec, Jigisha Rakholiya, Hannah Langenfeld, Cynthia S Crowson, Andy Abril, Jane Jaquith

J Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
Zesheng An, Gabriel Figueroa-Parra, Xian Zhou, Yanfeng Li, Jane Jaquith

Front Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
Zesheng An, Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
Matthew J Koster, Cynthia S Crowson, Rachel E Giblon, Jane M Jaquith, Ali Duarte-García

Ann Rheum Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis.
Yuan Liu, Jane M Jaquith, Kathleen Mccarthy-Fruin, Xingxing Zhu, Xian Zhou

Clin Rheumatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis